CD19 and type 1 diabetes mellitus: An earlier investigation failed to identify these structures using immunofluorescence staining for CD4+ T cells and CD19+ B cells in pancreases donated by four humans with type 1 diabetes (12–22 years old, 1–8 years of diabetes duration) [15].